BERRUTI, Alfredo
BERRUTI, Alfredo
A current perspective on treatment of adrenocortical carcinoma
2014-01-01 Massimo Terzolo, Silvia De Francia, Arianna Ardito, Paola Perotti, Laura Ferrari, Alfredo Berruti
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients
2006-01-01 DE FRANCIA S; PIRRO E; ZAPPIA F; DE MARTINO F; SPRIO AE; DAFFARA F; TERZOLO M; BERRUTI A; DI CARLO F; GHEZZO F
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbA phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine
2004-01-01 DONGIOVANNI V ;ADDEO A ;BERRUTI A ;BUFFONI L ;DONGIOVANNI D ;POLIMENI MA ;FISSORE C ;BARONE C ;BERTETTO O
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy. 2012 Apr 1;3(4):819-824. Epub 2012 Jan 16. PubMed Central PMCID: PMC3362404.
2012-01-01 Sottile A; Ortega C; Berruti A; Mangioni M; Saponaro S; Polo A; Prati V; Muto G; Aglietta M; Montemurro F.
A prospective study on adjuvant mitotane
2008-01-01 F. Daffara; B. Zaggia; A. Ardito; S. De Francia; G. Reimondo; M. Papotti; M. Volante; F. Di Carlo; A. Angeli; A. Berruti; M. Terzolo.
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study
1994-01-01 Dogliotti L; Berruti A; Buniva T; Zola P; Baù MG; Farris A; Sarobba MG; Bottini A; Alquati P; Deltetto F; Gosso P; Monzeglio C; Moro G; Sussio M; Perroni D.
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents
2019-01-01 Tucci M.; Roca E.; Ferrari L.; Pia A.; Dalla Volta A.; Bedussi F.; Buttigliero C.; Vittorio Scagliotti G.; Sigala S.; Berruti A.
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease.
2001-01-01 FIORENTINO C; A. BERRUTI; BOTTINI A; BODINI M; BRIZZI MP; BRUNELLI A; MARINI U; ALLEVI G; AGUGGINI S; TIRA A; ALQUATI P; OLIVETTI L; DOGLIOTTI L
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma
2009-01-01 Brizzi MP; Sculli CM; Ragni F; Porpiglia F; Tampellini M; Gorzegno G; Priola AM; Dogliotti L; Berruti A.
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases.
1995-01-01 BERRUTI A; PAZE E; FARA E; GORZEGNO G; DOGLIOTTI L
Adjunctive treatment of adrenocortical carcinoma
2008-01-01 Terzolo M; Berruti A.
Adjuvant mitotane in adrenocortical carcinoma - Reply
2007-01-01 TERZOLO M; FASSNACHT M; BERRUTI A
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
2019-01-01 Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M.
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008
2008-01-01 F. Daffara; A. Ardito; S. De Francia; G. Reimondo; M. Papotti; M. Volante; F. Di Carlo; A. Angeli; A. Berruti; M. Terzolo
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
2021-01-01 Kimpel O.; Bedrose S.; Megerle F.; Berruti A.; Terzolo M.; Kroiss M.; Mai K.; Dekkers O.M.; Habra M.A.; Fassnacht M.
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.
2010-01-01 Berruti A; Fassnacht M; Baudin E; Hammer G; Haak H; Leboulleux S; Skogseid B; Allolio B; Terzolo M.
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012-01-01 Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G.
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
2020-01-01 Fassnacht M.; Assie G.; Baudin E.; Eisenhofer G.; de la Fouchardiere C.; Haak H.R.; de Krijger R.; Porpiglia F.; Terzolo M.; Berruti A.
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
2010-01-01 Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J.
Advances in pancreatic neuroendocrine tumor treatment.
2011-01-01 Berruti A; Pia A; Terzolo M.